Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 326Gynecologic 15Thoracic 10Gastrointestinal 9Genitourinary 8Head & Neck 4Sarcoma 3Endocrine 3CNS 2Other solid neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Multiple Endocrine Neoplasia Type 1 5Breast Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Neoplasms by Site 1Hyperglycemia 1Breast Diseases 1

Interventions

selpercatinib 3Fulvestrant 3Fluorodeoxyglucose F18 3ribociclib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Letrozole 2Cyclophosphamide 2Alpelisib 2vandetanib 1tivozanib 1tipifarnib 1temsirolimus 1romidepsin 1pembrolizumab 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1fludarabine phosphate 1fludarabine 1exemestane 1entrectinib 1entinostat 1avelumab 1atezolizumab 1alectinib 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Fulvestrant × Endocrine × Clear all
NCT04300790 2025-07-29

METALLICA

MedSIR

Phase 2 Completed
69 enrolled
BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT02437318 2025-02-13

SOLAR-1

Novartis

Phase 3 Completed
572 enrolled 22 charts 1 FDA
BreastEndocrine

Breast Neoplasms, Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT02422615 2023-11-30

MONALEESA-3

Novartis

Phase 3 Completed
726 enrolled 17 charts 1 FDA
BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡